Literature DB >> 2105995

Immunoregulatory functions of paf-acether. IV. Enhancement of IL-1 production by muramyl dipeptide-stimulated monocytes.

P Salem1, S Deryckx, A Dulioust, E Vivier, Y Denizot, C Damais, C A Dinarello, Y Thomas.   

Abstract

paf-Acether (paf) is a phospholipid mediator of inflammation released from monocytes along with IL-1. In this study, we have examined the role of paf on IL-1 production by human monocytes. When paf from 1 nM to 5 microM, but not its precursor lyso paf, was added to monocytes in the presence of muramyl dipeptide (MDP) or LPS, a marked increase in IL-1 activity over the value with MDP alone was observed. In contrast, paf alone had minimal activity over the same dose range. Antibodies against rHu IL-1 alpha and rHu IL-1 beta neutralized the increased IL-1 activity. Interestingly, MDP that prompts monocytes to synthesize IL-1, induced the synthesis of paf, as well. Most of the paf produced remained cell-associated and always preceded IL-1 synthesis. When the paf receptor antagonist, L-652,731 was added to monocytes, it prevented the enhancement of IL-1 activity induced by exogenous paf. In contrast, L-652,731 had little effect on MDP-induced IL-1 synthesis in the absence of exogenous paf. This may indicate that there are alternative mechanisms involved in the sequences of events leading to IL-1 production. It is also conceivable that the paf receptor antagonist is not able to compete or inhibit endogenous paf as well as it does for exogenous paf. Nevertheless, exogenous paf in association with a second signal, modulates IL-1 production from human monocytes in a positive manner. This may constitute another means through which paf can modulate inflammatory and immune reactions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105995

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

2.  Fibronectin-fragment-induced cartilage chondrolysis is associated with release of catabolic cytokines.

Authors:  G A Homandberg; F Hui; C Wen; C Purple; K Bewsey; H Koepp; K Huch; A Harris
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

3.  Regulation of platelet-activating factor receptor expression in human B cells and B cell lines.

Authors:  C M Nguer; D Treton; M Rola-Pleszczynski; Z Mishal; Y Thomas; P Galanaud; Y Richard
Journal:  Lipids       Date:  1996-10       Impact factor: 1.880

Review 4.  Platelet-activating factor and the cytokine network in inflammatory processes.

Authors:  B Bonavida; J M Mencia-Huerta
Journal:  Clin Rev Allergy       Date:  1994

5.  Effect of platelet activating factor (PAF) on the migration of human lymphocytes.

Authors:  R G McFadden; M A Bishop; A N Caveney; L J Fraher
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

6.  Platelet-activating factor augments meningeal inflammation elicited by Haemophilus influenzae lipooligosaccharide in an animal model of meningitis.

Authors:  G C Townsend; W M Scheld
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

7.  Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes.

Authors:  P E Poubelle; D Gingras; C Demers; C Dubois; D Harbour; J Grassi; M Rola-Pleszczynski
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

8.  Stimulation and release of interleukin-1 from peritoneal macrophages of the mouse.

Authors:  A K Bahl; J C Foreman
Journal:  Agents Actions       Date:  1994-10

9.  Presence of paf-acether in rheumatic diseases.

Authors:  P Hilliquin; C J Menkes; S Laoussadi; J Benveniste; B Arnoux
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

10.  Relationship between interleukin-1 beta and platelet-activating factor in the pathogenesis of acute immune complex alveolitis in the rat.

Authors:  J S Warren
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.